The effect of various dialysis solutions on peritoneal membrane viability
Krediet, R.T.; Zweers, M.M.; Ho-dac-Pannekeet, M.M.; van der Wal, A.C.; Smit, W.; Douma, C.E.; Mateijsen, M.A.; Struijk, D.G.
Peritoneal Dialysis International Journal of the International Society for Peritoneal Dialysis 19(Suppl 2): S257-S266
1999
ISSN/ISBN: 0896-8608 PMID: 10406529 Document Number: 498790
Document emailed within 1 workday
Related Documents
Martikainen, T.A.; Teppo, A.-M.; Grönhagen-Riska, C.; Ekstrand, A.V. 2005: Glucose-free dialysis solutions: inductors of inflammation or preservers of peritoneal membrane? Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 25(5): 453-460Pawlaczyk, K.; Garcia-Lopez, E.; Kuzlan-Pawlaczyk, M.; Heimbürger, O.; Bergström, J.; Breborowicz, A.; Lindholm, B. 2001: The effect of icodextrin-based solutions on peritoneal transport in rats undergoing chronic peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 21(Suppl 3): S359-S361
Fourtounas, C.; Savidaki, E.; Roumelioti, M.; Dousdampanis, P.; Hardalias, A.; Kalliakmani, P.; Papachristou, E.; Drakopoulos, A.; Goumenos, D.S.; Vlachojannis, J.G. 2006: Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 22: 187-191
Jearnsujitwimol, V.; Eiam-Ong, S.; Kanjanabuch, T.; Wathanavaha, A.; Pansin, P. 2006: The effect of angiotensin Ii receptor blocker on peritoneal membrane transports in continuous ambulatory peritoneal dialysis patients Journal of the Medical Association of Thailand 89(Suppl 2): S188-S195
Carozzi, S.; Nasini, M.G.; Ravera, M.; Sanna, A.; Tirotta, A.; Lamperi, S. 1997: Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 13: 7-12
Ogata, S.; Yorioka, N.; Kiribayashi, K.; Naito, T.; Kuratsune, M.; Nishida, Y. 2003: Viability of, and basic fibroblast growth factor secretion by, human peritoneal mesothelial cells cultured with various components of peritoneal dialysis fluid Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 19: 2-5
Benaroia, M.; Morton, A.R.; Cheeseman, F.D.; Garland, J.S.; Toffelmire, E.B. 2008: Spontaneous peritoneal membrane rupture with extravasation of peritoneal fluid into the lower limbs and flank in a peritoneal dialysis patient Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 28(5): 554-557
Hassan, K.; Hassan, F.; Hassan, D.; Edgem, R.; Hassan, S. 2015: Do diabetic patients receiving conventional dialysis solutions benefit from peritoneal dialysis? Minerva Urologica e Nefrologica 67(4): 365-374
Montenegro, J. 2008: Phosphorus (P) chelant in dialysis: efficacy and cost. Peritoneal dialysis solutions Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 28(Suppl 5): 53-57
Olszowska, A.; Baczyński, D. 1998: Alternative dialysis solutions in continuous ambulatory peritoneal dialysis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 5(29): 307-309
Dai, H.-l.; Lin, A.-w.; Qian, J.-q.; Fang, W.; Ni, Z.-h.; Cao, L.-o.; Lin, X.-h.; Wu, Q.-w. 2010: Icodextrin improve angiogenesis of peritoneal membrane in continuous ambulatory peritoneal dialysis patients Zhonghua Yi Xue Za Zhi 90(40): 2843-2847
Paríková, A. 2008: Ultrafiltration and prevention of alteration of peritoneal membrane--determinants of success of peritoneal dialysis therapy Vnitrni Lekarstvi 54(12): 1127-1128
Aguilera, A.; Yáñez-Mo, M.; Selgas, R.; Sánchez-Madrid, F.; López-Cabrera, M. 2005: Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients Current Opinion in Investigational Drugs 6(3): 262-268
Krediet, R.T. 2001: Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 21(6): 560-567
Yamamoto, R.; Nakayama, M.; Hasegawa, T.; Miwako, N.; Yamamoto, H.; Yokoyami, K.; Ikeda, M.; Kato, N.; Hayakawa, H.; Takahashi, H.; Otsuka, Y.; Kawaguchi, Y.; Hosoya, T. 2002: High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 18: 131-134
Bruno, M.; Gabella, P.; Ramello, A. 2000: Use of amino acids in peritoneal dialysis solutions Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 20(Suppl 2): S166-S171
Paap, C.M.; Nahata, M.C. 1990: Stability of cefotaxime in two peritoneal dialysis solutions American Journal of Hospital Pharmacy 47(1): 147-150
Nolph, K.D.; Twardowski, Z.J.; Khanna, R.; Prowant, B.F.; Ponferrada, L.P.; Schmidt, L.M.; Moore, H.L. 1990: Tidal peritoneal dialysis with racemic or L-lactate solutions Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 10(2): 161-164
Garcia-Lopez, E.; Lindholm, B.; Tranaeus, A. 2000: Biocompatibility of new peritoneal dialysis solutions: clinical experience Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 20(Suppl 5): S48-S56
Martis, L. 1995: Industry perspectives on biocompatibility of peritoneal dialysis solutions Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 15(7 Suppl): S96-S99